Pfizer Ltd: A Comprehensive Overview

Pfizer Limited, an India-based multinational pharmaceutical company, operates within the Health Care sector, specifically in the Pharmaceuticals industry. The company is listed on the National Stock Exchange of India and trades in Indian Rupees (INR). As of April 24, 2025, Pfizer’s stock closed at 4248.9 INR. Over the past year, the stock has seen significant fluctuations, reaching a 52-week high of 6451.15 INR on September 1, 2024, and a low of 3701 INR on April 6, 2025. The company’s market capitalization stands at 195,610,000,000 INR, with a price-to-earnings ratio of 31.79.

Pfizer’s business operations are divided into four main categories: Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. The Vaccines Division is renowned for its Prevenar 13, a Pneumococcal Conjugate Vaccine approved for all age groups to combat pneumococcal disease caused by streptococcus pneumoniae bacteria. The Internal Medicine portfolio encompasses 17 specialties across seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular, and women’s healthcare.

The Hospital Business Unit of Pfizer focuses on supplying advanced anti-infectives to healthcare institutions such as hospitals and nursing homes. Meanwhile, the Inflammation and Immunology division is dedicated to discovering and developing novel therapeutics for chronic autoimmune diseases. Pfizer’s notable brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules, and Folvite.

Market Performance and Future Outlook

Pfizer’s stock has experienced notable volatility over the past year, reflecting the dynamic nature of the pharmaceutical industry. The significant drop from its 52-week high to its recent close price highlights the challenges and opportunities within the market. Investors and analysts continue to monitor Pfizer’s performance closely, given its substantial market cap and diverse portfolio.

As Pfizer navigates the complexities of the pharmaceutical landscape, its focus on innovation and development across its four business categories positions it as a key player in the industry. The company’s commitment to advancing healthcare solutions remains central to its strategy, promising potential growth and stability in the future.